O	O	0	16	Characterization	Characterization	B-NP	NN	O	0	ROOT	O
O	O	17	19	of	of	B-PP	IN	O	1	NMOD	O
O	O	20	21	a	a	B-NP	DT	O	6	NMOD	O
O	O	22	28	mutant	mutant	I-NP	JJ	B-cell_line	6	NMOD	B-cell_line
O	O	29	33	cell	cell	I-NP	NN	I-cell_line	6	NMOD	I-cell_line
O	O	34	38	line	line	I-NP	NN	I-cell_line	2	PMOD	I-cell_line
O	O	39	43	that	that	B-NP	WDT	O	6	NMOD	O
O	O	44	48	does	do	B-VP	VBZ	O	7	SBAR	O
O	O	49	52	not	not	I-VP	RB	O	8	VMOD	O
O	O	53	61	activate	activate	I-VP	VB	O	8	VC	O
T13	B-Entity	62	64	NF	NF	B-NP	NN	B-protein	13	NMOD	B-protein
T13	I-Entity	64	65	-	-	B-NP	HYPH	I-protein	13	NMOD	I-protein
T13	I-Entity	65	71	kappaB	kappaB	I-NP	NN	I-protein	10	OBJ	I-protein
O	O	72	74	in	in	B-PP	IN	O	10	VMOD	O
O	O	75	83	response	response	B-NP	NN	O	14	PMOD	O
O	O	84	86	to	to	B-PP	TO	O	15	NMOD	O
O	O	87	95	multiple	multiple	B-NP	JJ	O	18	NMOD	O
O	O	96	103	stimuli	stimulus	I-NP	NNS	O	16	PMOD	O
O	O	103	104	.	.	O	.	O	1	P	O

T14	B-Entity	106	114	Numerous	Numerous	B-NP	JJ	O	2	NMOD	O
T14	I-Entity	115	120	genes	gene	I-NP	NNS	O	16	SUB	O
O	O	121	129	required	require	B-VP	VBN	O	2	NMOD	O
O	O	130	136	during	during	B-PP	IN	O	3	VMOD	O
O	O	137	140	the	the	B-NP	DT	O	9	NMOD	O
O	O	141	147	immune	immune	I-NP	JJ	O	9	NMOD	O
O	O	148	150	or	or	I-NP	CC	O	9	NMOD	O
O	O	151	163	inflammation	inflammation	I-NP	NN	O	9	NMOD	O
O	O	164	172	response	response	I-NP	NN	O	15	NMOD	O
O	O	173	175	as	as	B-CONJP	RB	O	15	NMOD	O
O	O	176	180	well	well	I-CONJP	RB	O	10	DEP	O
O	O	181	183	as	as	I-CONJP	IN	O	10	DEP	O
O	O	184	187	the	the	B-NP	DT	O	15	NMOD	O
O	O	188	196	adhesion	adhesion	I-NP	NN	O	15	NMOD	O
O	O	197	204	process	process	I-NP	NN	O	4	PMOD	O
O	O	205	208	are	be	B-VP	VBP	O	0	ROOT	O
O	O	209	218	regulated	regulate	I-VP	VBN	O	16	VC	O
O	O	219	221	by	by	B-PP	IN	O	17	VMOD	O
T15	B-Entity	222	229	nuclear	nuclear	B-NP	JJ	B-protein	21	NMOD	B-protein
T15	I-Entity	230	236	factor	factor	I-NP	NN	I-protein	21	NMOD	I-protein
T15	I-Entity	237	243	kappaB	kappaB	I-NP	NN	I-protein	18	PMOD	I-protein
O	O	244	245	(	(	O	(	O	26	DEP	O
T16	B-Entity	245	247	NF	NF	B-NP	NN	B-protein	25	NMOD	B-protein
T16	I-Entity	247	248	-	-	B-NP	HYPH	I-protein	25	NMOD	I-protein
T16	I-Entity	248	254	kappaB	kappaB	I-NP	NN	I-protein	26	DEP	I-protein
O	O	254	255	)	)	O	)	O	21	NMOD	O
O	O	255	256	.	.	O	.	O	16	P	O

O	O	257	267	Associated	Associate	B-VP	VBN	O	12	VMOD	O
O	O	268	272	with	with	B-PP	IN	O	1	VMOD	O
O	O	273	276	its	its	B-NP	PRP$	O	4	NMOD	O
O	O	277	286	inhibitor	inhibitor	I-NP	NN	O	7	NMOD	O
O	O	286	287	,	,	I-NP	,	O	7	P	O
O	O	288	289	I	I	I-NP	NN	B-protein	7	NMOD	B-protein
O	O	290	296	kappaB	kappaB	I-NP	NN	I-protein	2	PMOD	I-protein
O	O	296	297	,	,	O	,	O	12	P	O
T17	B-Entity	298	300	NF	NF	B-NP	NN	B-protein	11	NMOD	B-protein
T17	I-Entity	300	301	-	-	B-NP	HYPH	I-protein	11	NMOD	I-protein
T17	I-Entity	301	307	kappaB	kappaB	I-NP	NN	I-protein	12	SUB	I-protein
O	O	308	315	resides	reside	B-VP	VBZ	O	0	ROOT	O
O	O	316	318	as	as	B-PP	IN	O	12	VMOD	O
O	O	319	321	an	an	B-NP	DT	O	16	NMOD	O
O	O	322	330	inactive	inactive	I-NP	JJ	O	16	NMOD	O
O	O	331	335	form	form	I-NP	NN	O	13	PMOD	O
O	O	336	338	in	in	B-PP	IN	O	16	NMOD	O
O	O	339	342	the	the	B-NP	DT	O	19	NMOD	O
O	O	343	352	cytoplasm	cytoplasm	I-NP	NN	O	17	PMOD	O
O	O	352	353	.	.	O	.	O	12	P	O

O	O	354	358	Upon	Upon	B-PP	IN	O	9	VMOD	O
O	O	359	370	stimulation	stimulation	B-NP	NN	O	1	PMOD	O
O	O	371	373	by	by	B-PP	IN	O	2	NMOD	O
O	O	374	381	various	various	B-NP	JJ	O	5	NMOD	O
O	O	382	388	agents	agent	I-NP	NNS	O	3	PMOD	O
O	O	388	389	,	,	O	,	O	9	P	O
O	O	390	391	I	I	B-NP	NN	B-protein	8	NMOD	B-protein
O	O	392	398	kappaB	kappaB	I-NP	NN	I-protein	9	SUB	I-protein
O	O	399	401	is	be	B-VP	VBZ	O	15	VMOD	O
O	O	402	413	proteolyzed	proteolyze	I-VP	VBN	O	9	VC	O
O	O	414	417	and	and	O	CC	O	9	VMOD	O
T18	B-Entity	418	420	NF	NF	B-NP	NN	B-protein	14	NMOD	B-protein
T18	I-Entity	420	421	-	-	B-NP	HYPH	I-protein	14	NMOD	I-protein
T18	I-Entity	421	427	kappaB	kappaB	I-NP	NN	I-protein	15	SUB	I-protein
O	O	428	440	translocates	translocate	B-VP	VBZ	O	0	ROOT	O
O	O	441	443	to	to	B-PP	TO	O	15	VMOD	O
O	O	444	447	the	the	B-NP	DT	O	18	NMOD	O
O	O	448	455	nucleus	nucleus	I-NP	NN	O	16	PMOD	O
O	O	455	456	,	,	O	,	O	18	P	O
O	O	457	462	where	where	B-ADVP	WRB	O	18	NMOD	O
O	O	463	465	it	it	B-NP	PRP	O	22	SUB	O
O	O	466	475	activates	activate	B-VP	VBZ	O	20	SBAR	O
O	O	476	479	its	its	B-NP	PRP$	O	25	NMOD	O
O	O	480	486	target	target	I-NP	NN	B-DNA	25	NMOD	B-DNA
O	O	487	492	genes	gene	I-NP	NNS	I-DNA	22	OBJ	I-DNA
O	O	492	493	.	.	O	.	O	15	P	O

O	O	494	497	The	The	B-NP	DT	O	3	NMOD	O
O	O	498	510	transduction	transduction	I-NP	NN	O	3	NMOD	O
O	O	511	519	pathways	pathway	I-NP	NNS	O	10	SUB	O
O	O	520	524	that	that	B-NP	WDT	O	3	NMOD	O
O	O	525	529	lead	lead	B-VP	VBP	O	4	SBAR	O
O	O	530	532	to	to	B-PP	TO	O	5	VMOD	O
O	O	533	534	I	I	B-NP	NN	B-protein	8	NMOD	B-protein
O	O	535	541	kappaB	kappaB	I-NP	NN	I-protein	9	NMOD	I-protein
O	O	542	554	inactivation	inactivation	I-NP	NN	O	6	PMOD	O
O	O	555	561	remain	remain	B-VP	VBP	O	0	ROOT	O
O	O	562	568	poorly	poorly	B-ADJP	RB	O	10	VMOD	O
O	O	569	579	understood	understand	I-ADJP	VBN	O	10	VC	O
O	O	579	580	.	.	O	.	O	10	P	O

O	O	581	583	In	In	B-PP	IN	O	6	VMOD	O
O	O	584	588	this	this	B-NP	DT	O	3	NMOD	O
O	O	589	594	study	study	I-NP	NN	O	1	PMOD	O
O	O	594	595	,	,	O	,	O	6	P	O
O	O	596	598	we	we	B-NP	PRP	O	6	SUB	O
O	O	599	603	have	have	B-VP	VBP	O	0	ROOT	O
O	O	604	617	characterized	characterize	I-VP	VBN	O	6	VC	O
O	O	618	619	a	a	B-NP	DT	O	10	NMOD	O
O	O	620	628	cellular	cellular	I-NP	JJ	O	10	NMOD	O
O	O	629	635	mutant	mutant	I-NP	NN	O	15	NMOD	O
O	O	635	636	,	,	O	,	O	15	P	O
O	O	637	640	the	the	B-NP	DT	O	15	NMOD	O
O	O	641	643	70	70	I-NP	CD	O	15	NMOD	O
O	O	643	644	/	/	I-NP	SYM	O	15	NMOD	O
O	O	644	646	Z3	Z3	I-NP	NN	B-protein	7	OBJ	B-protein
O	O	646	647	-	-	O	HYPH	O	15	P	O
O	O	647	654	derived	derive	B-VP	VBN	O	15	NMOD	O
O	O	655	656	1	1	B-NP	CD	O	26	NMOD	O
O	O	656	657	.	.	O	.	O	18	P	O
O	O	657	660	3E2	3E2	B-NP	CD	B-DNA	26	NMOD	B-DNA
O	O	661	667	murine	murine	I-NP	JJ	I-DNA	26	NMOD	I-DNA
O	O	668	671	pre	pre	I-NP	AFX	I-DNA	26	NMOD	I-DNA
O	O	671	672	-	-	I-NP	HYPH	B-cell_line	26	NMOD	B-cell_line
O	O	672	673	B	B	I-NP	NN	I-cell_line	26	NMOD	I-cell_line
O	O	674	678	cell	cell	I-NP	NN	I-cell_line	26	NMOD	I-cell_line
O	O	679	683	line	line	I-NP	NN	I-cell_line	17	VMOD	I-cell_line
O	O	683	684	,	,	O	,	O	15	P	O
O	O	685	689	that	that	B-NP	WDT	O	15	NMOD	O
O	O	690	694	does	do	B-VP	VBZ	O	28	SBAR	O
O	O	695	698	not	not	I-VP	RB	O	29	VMOD	O
O	O	699	707	activate	activate	I-VP	VB	O	29	VC	O
T19	B-Entity	708	710	NF	NF	B-NP	NN	B-protein	34	NMOD	B-protein
T19	I-Entity	710	711	-	-	B-NP	HYPH	I-protein	34	NMOD	I-protein
T19	I-Entity	711	717	kappaB	kappaB	I-NP	NN	I-protein	31	OBJ	I-protein
O	O	718	720	in	in	B-PP	IN	O	31	VMOD	O
O	O	721	729	response	response	B-NP	NN	O	35	PMOD	O
O	O	730	732	to	to	B-PP	TO	O	36	NMOD	O
O	O	733	740	several	several	B-NP	JJ	O	39	NMOD	O
O	O	741	748	stimuli	stimulus	I-NP	NNS	O	37	PMOD	O
O	O	748	749	.	.	O	.	O	6	P	O

O	O	750	752	We	We	B-NP	PRP	O	2	SUB	O
O	O	753	764	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT	O
O	O	765	769	that	that	B-SBAR	IN	O	2	VMOD	O
O	O	770	774	upon	upon	B-PP	IN	O	28	VMOD	O
O	O	775	786	stimulation	stimulation	B-NP	NN	O	4	PMOD	O
O	O	787	789	by	by	B-PP	IN	O	5	NMOD	O
O	O	790	808	lipopolysaccharide	lipopolysaccharide	B-NP	NN	O	27	NMOD	O
O	O	808	809	,	,	O	,	O	27	P	O
O	O	810	815	Taxol	Taxol	B-NP	NN	O	27	NMOD	O
O	O	815	816	,	,	O	,	O	27	P	O
O	O	817	824	phorbol	phorbol	B-NP	NN	O	13	NMOD	O
O	O	825	834	myristate	myristate	I-NP	NN	O	13	NMOD	O
O	O	835	842	acetate	acetate	I-NP	NN	O	27	NMOD	O
O	O	842	843	,	,	O	,	O	27	P	O
O	O	844	855	interleukin	interleukin	B-NP	NN	B-protein	16	NMOD	B-protein
O	O	855	856	-	-	B-NP	HYPH	I-protein	27	NMOD	I-protein
O	O	856	857	1	1	I-NP	CD	I-protein	16	NMOD	I-protein
O	O	857	858	,	,	O	,	O	27	P	O
O	O	859	861	or	or	O	CC	O	27	NMOD	O
O	O	862	868	double	double	B-NP	JJ	B-RNA	23	NMOD	B-RNA
O	O	868	869	-	-	I-NP	HYPH	I-RNA	23	NMOD	I-RNA
O	O	869	877	stranded	stranded	I-NP	JJ	I-RNA	23	NMOD	I-RNA
O	O	878	881	RNA	RNA	I-NP	NN	I-RNA	27	NMOD	I-RNA
O	O	881	882	,	,	I-NP	,	O	27	P	O
T1	B-Protein	883	884	I	I	I-NP	NN	B-protein	27	NMOD	B-protein
T1	I-Protein	885	891	kappaB	kappaB	I-NP	NN	I-protein	27	NMOD	I-protein
T1	I-Protein	892	897	alpha	alpha	I-NP	NN	I-protein	6	PMOD	I-protein
O	O	898	900	is	be	B-VP	VBZ	O	3	SBAR	O
O	O	901	904	not	not	I-VP	RB	O	28	VMOD	O
O	O	905	913	degraded	degrade	I-VP	VBN	O	28	VC	O
O	O	913	914	,	,	O	,	O	30	P	O
O	O	915	917	as	as	B-PP	IN	O	30	VMOD	O
O	O	918	919	a	a	B-NP	DT	O	34	NMOD	O
O	O	920	926	result	result	I-NP	NN	O	32	PMOD	O
O	O	927	929	of	of	B-PP	IN	O	34	NMOD	O
O	O	930	932	an	an	B-NP	DT	O	37	NMOD	O
O	O	933	940	absence	absence	I-NP	NN	O	35	PMOD	O
O	O	941	943	of	of	B-PP	IN	O	37	NMOD	O
O	O	944	951	induced	induce	B-NP	VBN	O	40	NMOD	O
O	O	952	967	phosphorylation	phosphorylation	I-NP	NN	O	38	PMOD	O
O	O	968	970	on	on	B-PP	IN	O	32	PMOD	O
T20	B-Entity	971	978	serines	serine	B-NP	NNS	O	41	PMOD	O
T20	I-Entity	979	981	32	32	B-NP	CD	O	42	NMOD	O
O	O	982	985	and	and	I-NP	CC	O	42	NMOD	O
T21	B-Entity	986	988	36	36	I-NP	CD	O	42	NMOD	O
O	O	988	989	.	.	O	.	O	2	P	O

O	O	990	997	Neither	Neither	O	CC	O	10	NMOD	O
O	O	998	999	a	a	B-NP	DT	O	3	NMOD	O
O	O	1000	1008	mutation	mutation	I-NP	NN	O	10	NMOD	O
O	O	1009	1011	in	in	B-PP	IN	O	3	NMOD	O
T2	B-Protein	1012	1013	I	I	B-NP	NN	B-protein	7	NMOD	B-protein
T2	I-Protein	1014	1020	kappaB	kappaB	I-NP	NN	I-protein	7	NMOD	I-protein
T2	I-Protein	1021	1026	alpha	alpha	I-NP	NN	I-protein	4	PMOD	I-protein
O	O	1027	1030	nor	nor	O	CC	O	10	NMOD	O
O	O	1031	1032	a	a	B-NP	DT	O	10	NMOD	O
O	O	1033	1041	mutation	mutation	I-NP	NN	O	19	NMOD	O
O	O	1042	1044	in	in	B-PP	IN	O	10	NMOD	O
T3	B-Protein	1045	1048	p50	p50	B-NP	NN	B-protein	14	NMOD	B-protein
O	O	1049	1051	or	or	I-NP	CC	O	14	NMOD	O
T4	B-Protein	1052	1056	relA	relA	I-NP	NN	B-protein	11	PMOD	B-protein
O	O	1056	1057	,	,	O	,	O	19	P	O
O	O	1058	1061	the	the	B-NP	DT	O	19	NMOD	O
O	O	1062	1065	two	two	I-NP	CD	O	19	NMOD	O
O	O	1066	1071	major	major	I-NP	JJ	O	19	NMOD	O
O	O	1072	1080	subunits	subunit	I-NP	NNS	O	29	SUB	O
O	O	1081	1083	of	of	B-PP	IN	O	19	NMOD	O
T22	B-Entity	1084	1086	NF	NF	B-NP	NN	B-protein	23	NMOD	B-protein
T22	I-Entity	1086	1087	-	-	B-NP	HYPH	I-protein	23	NMOD	I-protein
T22	I-Entity	1087	1093	kappaB	kappaB	I-NP	NN	I-protein	20	PMOD	I-protein
O	O	1094	1096	in	in	B-PP	IN	O	19	NMOD	O
O	O	1097	1101	this	this	B-NP	DT	O	27	NMOD	O
O	O	1102	1106	cell	cell	I-NP	NN	O	27	NMOD	O
O	O	1107	1111	line	line	I-NP	NN	O	24	PMOD	O
O	O	1111	1112	,	,	O	,	O	19	P	O
O	O	1113	1121	accounts	account	B-VP	VBZ	O	0	ROOT	O
O	O	1122	1125	for	for	B-PP	IN	O	29	VMOD	O
O	O	1126	1130	this	this	B-NP	DT	O	33	NMOD	O
O	O	1131	1146	phosphorylation	phosphorylation	I-NP	NN	O	33	NMOD	O
O	O	1147	1153	defect	defect	I-NP	NN	O	30	PMOD	O
O	O	1153	1154	.	.	O	.	O	29	P	O

O	O	1155	1157	As	As	B-PP	RB	O	3	DEP	O
O	O	1158	1162	well	well	I-PP	RB	O	3	DEP	O
O	O	1163	1165	as	as	I-PP	IN	O	30	VMOD	O
O	O	1166	1177	culminating	culminate	B-VP	VBG	O	3	SBAR	O
O	O	1178	1180	in	in	B-PP	IN	O	4	VMOD	O
O	O	1181	1184	the	the	B-NP	DT	O	8	NMOD	O
O	O	1185	1194	inducible	inducible	I-NP	JJ	O	8	NMOD	O
O	O	1195	1210	phosphorylation	phosphorylation	I-NP	NN	O	5	PMOD	O
O	O	1211	1213	of	of	B-PP	IN	O	8	NMOD	O
T5	B-Protein	1214	1215	I	I	B-NP	NN	B-protein	12	NMOD	B-protein
T5	I-Protein	1216	1222	kappaB	kappaB	I-NP	NN	I-protein	12	NMOD	I-protein
T5	I-Protein	1223	1228	alpha	alpha	I-NP	NN	I-protein	9	PMOD	I-protein
O	O	1229	1231	on	on	B-PP	IN	O	8	NMOD	O
T23	B-Entity	1232	1239	serines	serine	B-NP	NNS	O	13	PMOD	O
T23	I-Entity	1240	1242	32	32	B-NP	CD	O	14	NMOD	O
O	O	1243	1246	and	and	I-NP	CC	O	14	NMOD	O
T24	B-Entity	1247	1249	36	36	I-NP	CD	O	14	NMOD	O
O	O	1249	1250	,	,	O	,	O	30	P	O
O	O	1251	1254	all	all	B-NP	PDT	O	21	NMOD	O
O	O	1255	1258	the	the	I-NP	DT	O	21	NMOD	O
O	O	1259	1266	stimuli	stimulus	I-NP	NNS	O	30	SUB	O
O	O	1267	1271	that	that	B-NP	WDT	O	21	NMOD	O
O	O	1272	1275	are	be	B-VP	VBP	O	22	SBAR	O
O	O	1276	1284	inactive	inactive	B-ADJP	JJ	O	23	PRD	O
O	O	1285	1287	on	on	B-PP	IN	O	24	AMOD	O
O	O	1288	1289	1	1	B-NP	CD	O	25	PMOD	O
O	O	1289	1290	.	.	O	.	O	30	P	O
O	O	1290	1293	3E2	3E2	B-NP	NN	B-cell_line	29	NMOD	B-cell_line
O	O	1294	1299	cells	cell	I-NP	NNS	I-cell_line	30	SUB	I-cell_line
O	O	1300	1307	exhibit	exhibit	B-VP	VBP	O	0	ROOT	O
O	O	1308	1309	a	a	B-NP	DT	O	32	NMOD	O
O	O	1310	1321	sensitivity	sensitivity	I-NP	NN	O	30	OBJ	O
O	O	1322	1324	to	to	B-PP	TO	O	32	NMOD	O
O	O	1325	1328	the	the	B-NP	DT	O	35	NMOD	O
O	O	1329	1340	antioxidant	antioxidant	I-NP	JJ	O	33	PMOD	O
O	O	1341	1352	pyrrolidine	pyrrolidine	I-NP	NN	O	37	NMOD	O
O	O	1353	1368	dithiocarbamate	dithiocarbamate	I-NP	NN	O	35	NMOD	O
O	O	1369	1370	(	(	O	(	O	40	DEP	O
O	O	1370	1374	PDTC	PDTC	B-NP	NN	O	40	DEP	O
O	O	1374	1375	)	)	O	)	O	37	NMOD	O
O	O	1375	1376	.	.	O	.	O	30	P	O

O	O	1377	1379	In	In	B-PP	IN	O	20	VMOD	O
O	O	1380	1388	contrast	contrast	B-NP	NN	O	1	PMOD	O
O	O	1388	1389	,	,	O	,	O	20	P	O
O	O	1390	1397	stimuli	stimulus	B-NP	NNS	O	20	SUB	O
O	O	1398	1402	such	such	B-PP	JJ	O	6	PMOD	O
O	O	1403	1405	as	as	I-PP	IN	O	4	NMOD	O
O	O	1406	1418	hyperosmotic	hyperosmotic	B-NP	JJ	O	8	NMOD	O
O	O	1419	1424	shock	shock	I-NP	NN	O	11	NMOD	O
O	O	1425	1427	or	or	I-NP	CC	O	11	NMOD	O
O	O	1428	1439	phosphatase	phosphatase	I-NP	NN	O	11	NMOD	O
O	O	1440	1450	inhibitors	inhibitor	I-NP	NNS	O	6	PMOD	O
O	O	1450	1451	,	,	O	,	O	11	P	O
O	O	1452	1457	which	which	B-NP	WDT	O	11	NMOD	O
O	O	1458	1461	use	use	B-VP	VBP	O	13	SBAR	O
O	O	1462	1466	PDTC	PDTC	B-NP	NN	O	18	NMOD	O
O	O	1466	1467	-	-	B-NP	HYPH	O	18	NMOD	O
O	O	1467	1478	insensitive	insensitive	I-NP	JJ	O	18	NMOD	O
O	O	1479	1487	pathways	pathway	I-NP	NNS	O	14	OBJ	O
O	O	1487	1488	,	,	O	,	O	4	P	O
O	O	1489	1495	induce	induce	B-VP	VBP	O	0	ROOT	O
T6	B-Protein	1496	1497	I	I	B-NP	NN	B-protein	23	NMOD	B-protein
T6	I-Protein	1498	1504	kappaB	kappaB	I-NP	NN	I-protein	23	NMOD	I-protein
T6	I-Protein	1505	1510	alpha	alpha	I-NP	NN	I-protein	24	NMOD	I-protein
O	O	1511	1522	degradation	degradation	I-NP	NN	O	20	OBJ	O
O	O	1523	1525	in	in	B-PP	IN	O	20	VMOD	O
O	O	1526	1527	1	1	B-NP	CD	O	25	PMOD	O
O	O	1527	1528	.	.	I-NP	.	O	25	P	O
O	O	1528	1531	3E2	3E2	I-NP	NN	B-protein	25	PMOD	B-protein
O	O	1531	1532	.	.	O	.	O	20	P	O

O	O	1533	1541	Analysis	Analysis	B-NP	NN	O	9	NMOD	O
O	O	1542	1544	of	of	B-PP	IN	O	1	NMOD	O
O	O	1545	1548	the	the	B-NP	DT	O	5	NMOD	O
O	O	1549	1554	redox	redox	I-NP	NN	O	5	NMOD	O
O	O	1555	1561	status	status	I-NP	NN	O	2	PMOD	O
O	O	1562	1564	of	of	B-PP	IN	O	5	NMOD	O
O	O	1565	1566	1	1	B-NP	CD	O	6	PMOD	O
O	O	1566	1567	.	.	O	.	O	9	NMOD	O
O	O	1567	1570	3E2	3E2	B-NP	NN	B-protein	10	SUB	B-protein
O	O	1571	1575	does	do	B-VP	VBZ	O	0	ROOT	O
O	O	1576	1579	not	not	I-VP	RB	O	10	VMOD	O
O	O	1580	1586	reveal	reveal	I-VP	VB	O	10	VC	O
O	O	1587	1590	any	any	B-NP	DT	O	14	NMOD	O
O	O	1591	1601	difference	difference	I-NP	NN	O	12	OBJ	O
O	O	1602	1606	from	from	B-PP	IN	O	14	NMOD	O
O	O	1607	1611	wild	wild	B-NP	JJ	B-protein	20	NMOD	B-protein
O	O	1611	1612	-	-	I-NP	HYPH	I-protein	20	NMOD	I-protein
O	O	1612	1616	type	type	I-NP	NN	I-protein	20	NMOD	I-protein
O	O	1617	1620	70Z	70Z	I-NP	NN	I-protein	20	NMOD	I-protein
O	O	1620	1621	/	/	B-NP	SYM	I-protein	15	PMOD	I-protein
O	O	1621	1622	3	3	I-NP	CD	I-protein	20	NMOD	I-protein
O	O	1622	1623	.	.	O	.	O	10	P	O

O	O	1624	1626	We	We	B-NP	PRP	O	3	SUB	O
O	O	1627	1631	also	also	B-ADVP	RB	O	3	VMOD	O
O	O	1632	1638	report	report	B-VP	VBP	O	0	ROOT	O
O	O	1639	1643	that	that	B-SBAR	IN	O	3	VMOD	O
O	O	1644	1647	the	the	B-NP	DT	O	21	NMOD	O
O	O	1648	1653	human	human	I-NP	JJ	O	21	NMOD	O
O	O	1654	1655	T	T	I-NP	NN	O	21	NMOD	O
O	O	1655	1656	-	-	I-NP	HYPH	O	21	P	O
O	O	1656	1660	cell	cell	I-NP	NN	O	12	NMOD	O
O	O	1661	1669	leukemia	leukemia	I-NP	NN	O	12	NMOD	O
O	O	1670	1675	virus	virus	I-NP	NN	O	12	NMOD	O
O	O	1676	1680	type	type	I-NP	NN	O	21	NMOD	O
O	O	1681	1682	1	1	I-NP	CD	O	12	NMOD	O
O	O	1683	1684	(	(	O	(	O	18	DEP	O
O	O	1684	1688	HTLV	HTLV	B-NP	NN	O	17	NMOD	O
O	O	1688	1689	-	-	B-NP	HYPH	O	17	P	O
O	O	1689	1690	1	1	I-NP	CD	O	18	DEP	O
O	O	1690	1691	)	)	O	)	O	12	NMOD	O
O	O	1691	1692	-	-	O	HYPH	O	12	P	O
O	O	1692	1699	derived	derive	B-NP	VBN	O	21	NMOD	O
T7	B-Protein	1700	1703	Tax	Tax	I-NP	NN	B-protein	25	SUB	B-protein
O	O	1704	1709	trans	trans	O	AFX	O	25	VMOD	O
O	O	1709	1710	-	-	O	HYPH	O	25	P	O
O	O	1710	1719	activator	activator	B-NP	NN	O	25	SUB	O
O	O	1720	1727	induces	induce	B-VP	VBZ	O	4	SBAR	O
T25	B-Entity	1728	1730	NF	NF	B-NP	NN	B-protein	29	NMOD	B-protein
T25	I-Entity	1730	1731	-	-	I-NP	HYPH	I-protein	29	NMOD	I-protein
T25	I-Entity	1731	1737	kappaB	kappaB	I-NP	NN	I-protein	29	NMOD	I-protein
O	O	1738	1746	activity	activity	I-NP	NN	O	25	OBJ	O
O	O	1747	1749	in	in	B-PP	IN	O	25	VMOD	O
O	O	1750	1751	1	1	B-NP	CD	O	30	PMOD	O
O	O	1751	1752	.	.	O	.	O	4	DEP	O
O	O	1752	1755	3E2	3E2	O	NN	B-protein	32	VMOD	B-protein
O	O	1755	1756	,	,	O	,	O	35	P	O
O	O	1757	1767	suggesting	suggest	B-VP	VBG	O	33	VMOD	O
O	O	1768	1772	that	that	B-SBAR	IN	O	35	VMOD	O
O	O	1773	1777	this	this	B-NP	DT	O	39	NMOD	O
O	O	1778	1783	viral	viral	I-NP	JJ	B-protein	39	NMOD	B-protein
O	O	1784	1791	protein	protein	I-NP	NN	I-protein	40	SUB	I-protein
O	O	1792	1796	does	do	B-VP	VBZ	O	36	SBAR	O
O	O	1797	1800	not	not	I-VP	RB	O	40	VMOD	O
O	O	1801	1808	operate	operate	I-VP	VB	O	40	VC	O
O	O	1809	1812	via	via	B-PP	IN	O	42	VMOD	O
O	O	1813	1816	the	the	B-NP	DT	O	46	NMOD	O
O	O	1817	1826	defective	defective	I-NP	JJ	O	46	NMOD	O
O	O	1827	1834	pathway	pathway	I-NP	NN	O	43	PMOD	O
O	O	1834	1835	.	.	O	.	O	3	P	O

O	O	1836	1843	Finally	Finally	B-ADVP	RB	O	4	VMOD	O
O	O	1843	1844	,	,	O	,	O	4	P	O
O	O	1845	1847	we	we	B-NP	PRP	O	4	SUB	O
O	O	1848	1852	show	show	B-VP	VBP	O	0	ROOT	O
O	O	1853	1857	that	that	B-SBAR	IN	O	4	VMOD	O
O	O	1858	1861	two	two	B-NP	CD	O	21	NMOD	O
O	O	1862	1867	other	other	I-NP	JJ	O	6	NMOD	O
O	O	1868	1869	I	I	I-NP	NN	B-protein	10	NMOD	B-protein
O	O	1870	1876	kappaB	kappaB	I-NP	NN	I-protein	10	NMOD	I-protein
O	O	1877	1886	molecules	molecule	I-NP	NNS	I-protein	6	NMOD	I-protein
O	O	1886	1887	,	,	O	,	O	21	P	O
T8	B-Protein	1888	1889	I	I	B-NP	NN	B-protein	14	NMOD	B-protein
T8	I-Protein	1890	1896	kappaB	kappaB	I-NP	NN	I-protein	14	NMOD	I-protein
T8	I-Protein	1897	1901	beta	beta	I-NP	NN	I-protein	21	NMOD	I-protein
O	O	1902	1905	and	and	O	CC	O	21	NMOD	O
O	O	1906	1909	the	the	B-NP	DT	O	21	NMOD	O
O	O	1910	1918	recently	recently	I-NP	RB	O	18	AMOD	O
O	O	1919	1929	identified	identify	I-NP	VBN	O	21	NMOD	O
T9	B-Protein	1930	1931	I	I	I-NP	NN	B-protein	21	NMOD	B-protein
T9	I-Protein	1932	1938	kappaB	kappaB	I-NP	NN	I-protein	21	NMOD	I-protein
T9	I-Protein	1939	1946	epsilon	epsilon	I-NP	NN	I-protein	23	SUB	I-protein
O	O	1946	1947	,	,	O	,	O	21	P	O
O	O	1948	1951	are	be	B-VP	VBP	O	5	SBAR	O
O	O	1952	1955	not	not	I-VP	RB	O	23	VMOD	O
O	O	1956	1964	degraded	degrade	I-VP	VBN	O	23	VC	O
O	O	1965	1967	in	in	B-PP	IN	O	25	VMOD	O
O	O	1968	1971	the	the	B-NP	DT	O	32	NMOD	O
O	O	1972	1973	1	1	I-NP	CD	O	29	AMOD	O
O	O	1973	1974	.	.	I-NP	.	O	32	NMOD	O
O	O	1974	1977	3E2	3E2	I-NP	NN	B-cell_line	32	NMOD	B-cell_line
O	O	1978	1982	cell	cell	I-NP	NN	I-cell_line	32	NMOD	I-cell_line
O	O	1983	1987	line	line	I-NP	NN	I-cell_line	26	PMOD	I-cell_line
O	O	1988	1997	following	follow	B-PP	VBG	O	25	VMOD	O
O	O	1998	2009	stimulation	stimulation	B-NP	NN	O	33	PMOD	O
O	O	2009	2010	.	.	O	.	O	4	P	O

O	O	2011	2014	Our	Our	B-NP	PRP$	O	2	NMOD	O
O	O	2015	2022	results	result	I-NP	NNS	O	3	SUB	O
O	O	2023	2034	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT	O
O	O	2035	2039	that	that	B-SBAR	IN	O	3	VMOD	O
O	O	2040	2041	1	1	B-NP	CD	O	7	NMOD	O
O	O	2041	2042	.	.	I-NP	.	O	5	P	O
O	O	2042	2045	3E2	3E2	I-NP	NN	B-protein	8	SUB	B-protein
O	O	2046	2048	is	be	B-VP	VBZ	O	4	SBAR	O
O	O	2049	2050	a	a	B-NP	DT	O	12	NMOD	O
O	O	2051	2059	cellular	cellular	I-NP	JJ	B-protein	12	NMOD	B-protein
O	O	2060	2072	transduction	transduction	I-NP	NN	I-protein	12	NMOD	I-protein
O	O	2073	2079	mutant	mutant	I-NP	NN	I-protein	8	PRD	I-protein
O	O	2080	2090	exhibiting	exhibit	B-VP	VBG	O	12	NMOD	O
O	O	2091	2092	a	a	B-NP	DT	O	15	NMOD	O
O	O	2093	2099	defect	defect	I-NP	NN	O	13	OBJ	O
O	O	2100	2102	in	in	B-PP	IN	O	13	VMOD	O
O	O	2103	2104	a	a	B-NP	DT	O	18	NMOD	O
O	O	2105	2109	step	step	I-NP	NN	O	16	PMOD	O
O	O	2110	2114	that	that	B-NP	WDT	O	18	NMOD	O
O	O	2115	2117	is	be	B-VP	VBZ	O	19	SBAR	O
O	O	2118	2126	required	require	I-VP	VBN	O	20	VC	O
O	O	2127	2129	by	by	B-PP	IN	O	21	VMOD	O
O	O	2130	2137	several	several	B-NP	JJ	O	24	AMOD	O
O	O	2138	2147	different	different	I-NP	JJ	O	25	NMOD	O
O	O	2148	2155	stimuli	stimulus	I-NP	NNS	O	22	PMOD	O
O	O	2156	2158	to	to	B-VP	TO	O	27	VMOD	O
O	O	2159	2167	activate	activate	I-VP	VB	O	20	VMOD	O
T26	B-Entity	2168	2170	NF	NF	B-NP	NN	B-protein	30	NMOD	B-protein
T26	I-Entity	2170	2171	-	-	B-NP	HYPH	I-protein	30	NMOD	I-protein
T26	I-Entity	2171	2177	kappaB	kappaB	I-NP	NN	I-protein	27	OBJ	I-protein
O	O	2177	2178	.	.	O	.	O	3	P	O

O	O	2179	2181	In	In	B-PP	IN	O	6	VMOD	O
O	O	2182	2190	addition	addition	B-NP	NN	O	1	PMOD	O
O	O	2190	2191	,	,	O	,	O	6	P	O
O	O	2192	2196	this	this	B-NP	DT	O	5	NMOD	O
O	O	2197	2205	analysis	analysis	I-NP	NN	O	6	SUB	O
O	O	2206	2214	suggests	suggest	B-VP	VBZ	O	0	ROOT	O
O	O	2215	2216	a	a	B-NP	DT	O	9	NMOD	O
O	O	2217	2223	common	common	I-NP	JJ	O	9	NMOD	O
O	O	2224	2228	step	step	I-NP	NN	O	6	OBJ	O
O	O	2229	2231	in	in	B-PP	IN	O	9	NMOD	O
O	O	2232	2235	the	the	B-NP	DT	O	13	NMOD	O
O	O	2236	2245	signaling	signaling	I-NP	NN	O	13	NMOD	O
O	O	2246	2254	pathways	pathway	I-NP	NNS	O	10	PMOD	O
O	O	2255	2259	that	that	B-NP	WDT	O	13	NMOD	O
O	O	2260	2267	trigger	trigger	B-VP	VBP	O	14	SBAR	O
T10	B-Protein	2268	2269	I	I	B-NP	NN	B-protein	18	NMOD	B-protein
T10	I-Protein	2270	2276	kappaB	kappaB	I-NP	NN	I-protein	18	NMOD	I-protein
T10	I-Protein	2277	2282	alpha	alpha	I-NP	NN	I-protein	28	NMOD	I-protein
O	O	2282	2283	,	,	O	,	O	28	P	O
T11	B-Protein	2284	2285	I	I	B-NP	NN	B-protein	22	NMOD	B-protein
T11	I-Protein	2286	2292	kappaB	kappaB	I-NP	NN	I-protein	22	NMOD	I-protein
T11	I-Protein	2293	2297	beta	beta	I-NP	NN	I-protein	28	NMOD	I-protein
O	O	2297	2298	,	,	O	,	O	28	P	O
O	O	2299	2302	and	and	O	CC	O	28	NMOD	O
T12	B-Protein	2303	2304	I	I	B-NP	NN	B-protein	28	NMOD	B-protein
T12	I-Protein	2305	2311	kappaB	kappaB	I-NP	NN	I-protein	28	NMOD	I-protein
T12	I-Protein	2312	2319	epsilon	epsilon	I-NP	NN	I-protein	28	NMOD	I-protein
O	O	2320	2331	degradation	degradation	I-NP	NN	O	15	OBJ	O
O	O	2331	2332	.	.	O	.	O	6	P	O
